Working to facilitate rapid translation of scientific discoveries into therapeutics

Barry D. Garfinkle


Barry D. Garfinkle, PhD

Dr. Garfinkle has over 35 years in the Pharmaceutical Industry in the areas of Vaccines, Biologics and Sterile Pharmaceuticals. After earning his Ph.D. in Virology and Biochemistry, he did a postdoctoral fellowship at the Roche Institute of Molecular Biology. He joined Merck & Company in 1975 and held positions of increasing responsibility in the manufacturing area including: V.P of Quality, V.P Vaccine Technology and Engineering, and V.P Biological Sciences and Strategy prior to retiring. He also was active outside Merck and has served on the USP council of Experts including Chairing the Committee on Vaccines and Virology, and is a member of the General Chapters Committee. As a member of the USP he has worked with the EP on harmonization of chapters in the two pharmacopaeias. He has also published numerous papers on vaccines, biologics, and sterile pharmaceuticals over his career. He is now a consultant to the industry and serves on several scientific advisory boards.

2013-2021©European Society for Translational Medicine (EUSTM)